Medicon Village

As Jack Egelund was appointed CEO of Diagonal Bio at Medicon Village a year ago, he entered a company founded on the idea to provide a diagnostic platform for ultra-rapid, parallel, accurate and cost-efficient detection of any kind of pathogen.

– To have the opportunity to be part of commercializing a brand new way of diagnosing, combining speed and accuracy with cost-efficient detection, was a once in a lifetime chance. My previous experience from microbiome research services for pre-clinical and clinical studies, together with learnings from building teams and executing commercial strategies, comes in handy as we take our technology to the market.

Besides from acting CEO at Diagonal Bio, Jack Egelund is part of The Nordic Mentor Network for Entrepreneurship (NOME) since December. This elite Nordic mentoring program for promising life science projects and startups is driven by the vision of transforming Nordic life science startups into internationally renowned commercial successes. Selected Nordic startups are being matched with highly skilled volunteer professionals to help them reach their goals and technology milestones. One of the latter is Carl Borrebaeck, Professor at Department of Immunotechnology, Lund University, and founder of several life science businesses at Medicon Village, like Alligator Bioscience, Immunovia, SenzaGen and PainDrainer.

– Having meetings with mentors every sixth week, I get the chance to gain from their experience in being part in building Diagonal Bio to a one-of-a-kind business. I benefit dearly, benchmarking their knowledge and powerful leadership.

One reason why Jack Egelund decided to join Diagonal Bio was inspiring serial entrepreneur Kush Punyani, known from i.a. SmiLe Incubator member Spermosen, being founder and major shareholder. He came up with the idea for the Diagonal Bio diagnostic platform Panviral, using a technology based on rapid isothermal amplification of a pathogen’s genome and unique in many ways. The reaction is tracked in real-time, for an ultra-rapid and quantitative result. Test progress is monitored using a proprietary and patent-pending electrochemical sensing method. With Panviral, correct and accurate diagnoses are achieved at a fraction of the cost, time and expertise required by current methods, such as PCR. The speed, mobility, parallelisation and ease-of-use also mean that testing facilities can be set up basically anywhere.

More on Jack Egelund:

More on Diagonal Bio:

More on NOME: